CoChat

Enhancing the landscape of colorectal cancer using targeted deep sequencing

Open access

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

Abstract

Targeted next-generation sequencing (NGS) technology detects specific mutations that can provide treatment opportunities for colorectal cancer (CRC) patients. We included 145 CRC patients who underwent surgery. We analyzed the mutation frequencies of common actionable genes and their association with clinicopathological characteristics and oncologic outcomes using targeted NGS. Approximately 97.9% (142) of patients showed somatic mutations. Frequent mutations were observed in TP53 (70%), APC (60%), and KRAS (49%). TP53 mutations were significantly linked to higher overall stage (p = 0.038) and lower disease-free survival (DFS) (p = 0.039). ATM mutation was significantly associated with higher tumor stage (p = 0.012) and shorter overall survival (OS) (p = 0.041). Stage 3 and 4 patients with ATM mutations (p = 0.023) had shorter OS, and FBXW7 mutation was significantly associated with shorter DFS (p = 0.002). However, the OS of patients with or without TP53, RAS, APC, PIK3CA, and SMAD4 mutations did not differ significantly (p = 0.59, 0.72, 0.059, 0.25, and 0.12, respectively). Similarly, the DFS between patients with RAS, APC, PIK3CA, and SMAD4 mutations and those with wild-type were not statistically different (p = 0.3, 0.79, 0.13, and 0.59, respectively). In multivariate Cox regression analysis, ATM mutation was an independent biomarker for poor prognosis of OS (p = 0.043). A comprehensive analysis of the molecular markers for CRC can provide insights into the mechanisms underlying disease progression and help optimize a personalized therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-021-87486-3

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Oncoplot of the top 15 most frequently mutated genes in 115 cases. This shows the list of top 15 genes arranged based on the total number of variants in each gene, and the percentage following each gene represents the ratio of tumor samples with its genetic alteration to the total samples. Colored squares indicate the mutated genes, while gray squares indicate the non-mutated genes. Note 1: The oncoplot was depicted with 115 cases which are available for the genetic alterations of APC. Note 2: Variants annotated as Multi_Hit refer to those genes that mutated more than once in the same sample.
Figure 1 Oncoplot of the top 15 most frequently mutated genes in 115 cases. This shows the list of top 15 genes arranged based on the total number of variants in each gene, and the percentage following each gene represents the ratio of tumor samples with its genetic alteration to the total samples. Colored squares indicate the mutated genes, while gray squares indicate the non-mutated genes. Note 1: The oncoplot was depicted with 115 cases which are available for the genetic alterations of APC. Note 2: Variants annotated as Multi_Hit refer to those genes that mutated more than once in the same sample.CC BY · PubMed Central
Figure 2 The variant prevalence and spectrum of TP53 (A), KRAS (B), APC (C), PIK3CA (D), SMAD4 (E) genes in this cohort. All graphs depict a lollipop plot showing identified variants relative to a schematic representation of the gene. Y-axis represent total number of mutations at each residue.
Figure 2 The variant prevalence and spectrum of TP53 (A), KRAS (B), APC (C), PIK3CA (D), SMAD4 (E) genes in this cohort. All graphs depict a lollipop plot showing identified variants relative to a schematic representation of the gene. Y-axis represent total number of mutations at each residue.CC BY · PubMed Central
Figure 3 Mutually exclusive and co-occurring gene pairs in our dataset presented in a triangular matrix. Bluish green indicates a tendency toward co-occurrence, whereas brown indicates a tendency toward mutually exclusiveness.
Figure 3 Mutually exclusive and co-occurring gene pairs in our dataset presented in a triangular matrix. Bluish green indicates a tendency toward co-occurrence, whereas brown indicates a tendency toward mutually exclusiveness.CC BY · PubMed Central
Figure 4 Kaplan–Meier curve for OS in 145 CRC patients by mutational status, including TP53 (A), RAS (B), APC (C), PIK3CA (D), SMAD4 (E), BRAF (F), ATM (G), and FBXW7 (H).
Figure 4 Kaplan–Meier curve for OS in 145 CRC patients by mutational status, including TP53 (A), RAS (B), APC (C), PIK3CA (D), SMAD4 (E), BRAF (F), ATM (G), and FBXW7 (H).CC BY · PubMed Central
Figure 5 Kaplan–Meier curve for DFS in 145 CRC patients by mutational status, including TP53 (A), RAS (B), APC (C), PIK3CA (D), SMAD4 (E), BRAF (F), ATM (G), and FBXW7 (H).
Figure 5 Kaplan–Meier curve for DFS in 145 CRC patients by mutational status, including TP53 (A), RAS (B), APC (C), PIK3CA (D), SMAD4 (E), BRAF (F), ATM (G), and FBXW7 (H).CC BY · PubMed Central
Figure 6 Forest plots for CRC prognostic markers. Multivariable Cox-proportional hazards analysis was performed to identify the prognostic markers that may predict OS (A) and DFS (B). Error bars represent hazard ratios and their 95% confidence intervals.
Figure 6 Forest plots for CRC prognostic markers. Multivariable Cox-proportional hazards analysis was performed to identify the prognostic markers that may predict OS (A) and DFS (B). Error bars represent hazard ratios and their 95% confidence intervals.CC BY · PubMed Central
Figure 7 Gene-wise distribution of variant allele frequencies (VAF) for genes with more than two instances of somatic mutations (A), distribution of VAFs depending on mutation types (B), and Kaplan–Meier curve for OS in the MSKCC cohort stratified by presence of genes with relatively lower VAF (C).
Figure 7 Gene-wise distribution of variant allele frequencies (VAF) for genes with more than two instances of somatic mutations (A), distribution of VAFs depending on mutation types (B), and Kaplan–Meier curve for OS in the MSKCC cohort stratified by presence of genes with relatively lower VAF (C).CC BY · PubMed Central
Figure 8 Oncoplot of all genes in which either gene fusion or copy number variation (CNV) was identified. This figure shows the list of genes arranged based on the total number of variants in each gene and the percentage of each gene, which is the ratio of tumor samples with this genetic alteration to total samples.
Figure 8 Oncoplot of all genes in which either gene fusion or copy number variation (CNV) was identified. This figure shows the list of genes arranged based on the total number of variants in each gene and the percentage of each gene, which is the ratio of tumor samples with this genetic alteration to total samples.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Cited by

See all 66

Metadata

Authors
Lee, C. S., Song, I. H., Lee, A., Kang, J., Lee, Y. S., Lee, I. K., Song, Y. S., & Lee, S. H.
Affiliations
  • The Catholic University of Korea Seoul St. Mary's Hospital (KR)
  • Konyang University (KR)
Corresponding author
  • Song, Young Soo
  • Lee, Sung Hak
Venue
Scientific Reports
Published
2021-04-14
Volume
11
Issue
1
Pages
8154-8154
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3155663898
Cited by
64
References
52
Citations by year
2026: 6 · 2025: 15 · 2024: 12 · 2023: 14 · 2022: 14 · 2021: 3
FWCI
3.91
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Preprints.org (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Research Foundation
  • National Research Foundation of Korea (2019R1F1A1062367)
  • Ministry of Science and ICT, South Korea
Topics
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
colorectal cancer, somatic mutations, actionable genes, TP53, APC, KRAS, ATM, FBXW7, PIK3CA, SMAD4, prognostic factors, disease-free survival, overall survival, tumor stage, targeted deep sequencing
MeSH terms
Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Mutation, Prognosis, Biomarkers, Tumor, Colorectal Neoplasms, Survival Analysis, Sequence Analysis, DNA, High-Throughput Nucleotide Sequencing, Neoplasm Grading

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enhancing the landscape of colorectal cancer using targeted deep sequencing. https://app.cochat.ai/papers/10.1038/s41598-021-87486-3
The paper
Lee, C. S., Song, I. H., Lee, A., Kang, J., Lee, Y. S., Lee, I. K., Song, Y. S., & Lee, S. H. (2021). Enhancing the landscape of colorectal cancer using targeted deep sequencing. Scientific Reports. https://doi.org/10.1038/s41598-021-87486-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.